The amyloid cascade hypothesis: an updated critical review

KP Kepp, NK Robakis, PF Høilund-Carlsen, SL Sensi… - Brain, 2023 - academic.oup.com
Results from recent clinical trials of antibodies that target amyloid-β (Aβ) for Alzheimer's
disease have created excitement and have been heralded as corroboration of the amyloid …

[HTML][HTML] A current view on Tau protein phosphorylation in Alzheimer's disease

S Wegmann, J Biernat, E Mandelkow - Current opinion in neurobiology, 2021 - Elsevier
The functions of the neuronal microtubule-associated protein Tau in the central nervous
system are regulated by manifold posttranslational modifications at more than 50 sites. Tau …

Assembly of recombinant tau into filaments identical to those of Alzheimer's disease and chronic traumatic encephalopathy

S Lövestam, FA Koh, B van Knippenberg, A Kotecha… - Elife, 2022 - elifesciences.org
Abundant filamentous inclusions of tau are characteristic of more than 20
neurodegenerative diseases that are collectively termed tauopathies. Electron cryo …

[HTML][HTML] Tau PTM profiles identify patient heterogeneity and stages of Alzheimer's disease

H Wesseling, W Mair, M Kumar, CN Schlaffner, S Tang… - Cell, 2020 - cell.com
To elucidate the role of Tau isoforms and post-translational modification (PTM) stoichiometry
in Alzheimer's disease (AD), we generated a high-resolution quantitative proteomics map of …

Revisiting the grammar of Tau aggregation and pathology formation: how new insights from brain pathology are shaping how we study and target Tauopathies

G Limorenko, HA Lashuel - Chemical Society Reviews, 2022 - pubs.rsc.org
Converging evidence continues to point towards Tau aggregation and pathology formation
as central events in the pathogenesis of Alzheimer's disease and other Tauopathies …

Acetylated tau inhibits chaperone-mediated autophagy and promotes tau pathology propagation in mice

B Caballero, M Bourdenx, E Luengo, A Diaz… - Nature …, 2021 - nature.com
Disrupted homeostasis of the microtubule binding protein tau is a shared feature of a set of
neurodegenerative disorders known as tauopathies. Acetylation of soluble tau is an early …

The complexity of tau in Alzheimer's disease

NN Naseri, H Wang, J Guo, M Sharma, W Luo - Neuroscience letters, 2019 - Elsevier
Alzheimer's disease (AD) is characterized by two major pathological lesions in the brain,
amyloid plaques and neurofibrillary tangles (NFTs) composed mainly of amyloid-β (Aβ) …

Tau and tauopathies

T Arendt, JT Stieler, M Holzer - Brain research bulletin, 2016 - Elsevier
Most neurodegenerative diseases are characterized by intracellular aggregates of insoluble
proteins. As for the majority of these disorders, aetiology and pathogenesis are only poorly …

The road to restoring neural circuits for the treatment of Alzheimer's disease

RG Canter, J Penney, LH Tsai - Nature, 2016 - nature.com
Alzheimer's disease is a progressive loss of memory and cognition, for which there is no
cure. Although genetic studies initially suggested a primary role for amyloid-in Alzheimer's …

Soluble TREM2 ameliorates tau phosphorylation and cognitive deficits through activating transgelin-2 in Alzheimer's disease

X Zhang, L Tang, J Yang, L Meng, J Chen… - Nature …, 2023 - nature.com
Triggering receptor expressed on myeloid cells 2 (TREM2) is a transmembrane protein that
is predominantly expressed by microglia in the brain. The proteolytic shedding of TREM2 …